Paratek Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$9.41M, a 28.5% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$44.5M, a 34.4% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$46.2M, a 12.3% decline from 2021.
  • Paratek Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$41.1M, a 45.5% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$75.5M, a 34.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$44.5M -$9.41M +$3.76M +28.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$48.3M -$15.8M -$2.09M -15.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$46.2M -$2.84M +$24.4M +89.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 -$70.7M -$16.5M -$2.77M -20.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$67.9M -$13.2M -$27.3M -193% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$40.6M -$13.7M +$508K +3.57% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$41.1M -$27.3M -$9.75M -55.6% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 -$31.4M -$13.7M +$2.23M +14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$33.6M $14.1M +$32.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$66.1M -$14.2M +$9.36M +39.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$75.5M -$17.5M +$5.65M +24.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$81.2M -$15.9M +$13.1M +45% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 -$94.2M -$18.4M +$11.7M +38.8% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 -$106M -$23.6M +$9.74M +29.2% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 -$116M -$23.2M -$3.15M -15.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$112M -$29M +$600K +2.03% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-29
Q2 2019 -$113M -$30.1M -$2.39M -8.63% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-29
Q1 2019 -$111M -$33.3M -$6.6M -24.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-29
Q4 2018 -$104M -$20M +$833K +3.99% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$105M -$29.6M -$9.31M -45.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$95.6M -$27.7M -$11.1M -66.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$84.5M -$26.7M +$59K +0.22% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 -$84.6M -$20.9M +$5.02M +19.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$89.6M -$20.3M +$2.82M +12.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$92.4M -$16.6M +$13.1M +44.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$106M -$26.8M +$3.96M +12.9% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$109M -$25.9M -$5.52M -27.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$104M -$23.1M +$259K +1.11% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$104M -$29.8M -$14.1M -89.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$90.2M -$30.7M -$20.1M -189% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$70.1M -$20.4M -$18.5M -966% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$51.6M -$23.4M -$20.3M -660% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$31.3M -$15.7M -$13.8M -734% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$17.5M -$10.6M -$9.7M -1042% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$7.8M -$1.91M +$3.61M +65.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$11.4M -$3.08M +$1.61M +34.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$13M -$1.88M +$4.81M +71.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$17.8M -$931K +$9.54M +91.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$27.4M -$5.52M +$1M +15.4% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-14
Q3 2013 -$28.4M -$4.69M -$9.59M -196% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$18.8M -$6.69M -$1.6M -31.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$17.2M -$10.5M -$5.33M -104% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 -$11.9M -$6.52M -$11.8M -222% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$10K $4.9M +$9.86M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$9.87M -$5.1M -$2.88M -130% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$7M -$5.14M -$3.23M -169% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$3.76M $5.33M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$4.96M -$2.22M -80.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 -$2.22M -$169K -8.24% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-12
Q1 2011 -$1.91M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-12
Q3 2010 -$2.74M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$2.05M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.